PMCB
PharmaCyte Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.34
+0.53%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-54.2%
Return on equity
-44.0%
Return on assets
-23.5%
Return on invested capital
0.00x
Asset turnover
-$3.9M
Cash from operations
$2.84
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jul 1, 2026